Skip to content

Clinical Application Research on Artificial Intelligence-Assisted Diagnosis and Treatment of Sepsis

Clinical Application Research on Artificial Intelligence-Assisted Diagnosis and Treatment of Sepsis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096522
Enrollment
Unknown
Registered
2025-01-24
Start date
2025-04-29
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Unblinded LSTM low-precision model set:None
Blinded LSTM low-precision model set:None
A group of unblinded LSTM medium-precision models:None
Blinded LSTM medium-precision model set:None
Unblinded LSTM high-precision model set:None
Blinded LSTM high-precision model set:None
Unblinded Coxphm model group:None
Blinded Coxphm model group:None
Unblinded Fda ImmunoScore model group:None
Blinded Fda ImmunoScore model set:None
Unblinded CBC model group:None
Blinded CBC model group:None
A randomized model (sham device) assisted the control group:None
No model-assisted control group:None

Sponsors

Guilin Meidical University The Second Affiliated Hospital of Guilin Meidical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria for Patients: Admission to the intensive care unit (ICU) with signed informed consent (can be signed by a legal representative). Inclusion Criteria for Clinicians: Possession of a medical practice license and experience in the diagnosis and treatment of sepsis, with signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for Patients: 1. Diagnosed with or able to be diagnosed with sepsis within 30 minutes of admission to the ICU (suspected infection + SOFA score >=2). 2. No suspected infection and an expected ICU stay of no more than 48 hours, especially postoperative recovery patients without suspected infection. Exclusion Criteria for Clinicians: None.

Design outcomes

Primary

MeasureTime frame
Clinicians' diagnostic AUC;Change in clinician-diagnosed AUC compared to the control group;

Secondary

MeasureTime frame
Clinicians' diagnostic time;Clinicians' diagnostic specificity;Clinicians' diagnostic sensitivity;Accuracy of early antibiotic administration;The time of antibiotic administration;Patients' ICU length of stay;Patients' in-hospital mortality rate;Patients' 28-day mortality rate;

Countries

China

Contacts

Public ContactLi Ma

Guilin Meidical University, The Second Affiliated Hospital of Guilin Meidical University

xbj8879@163.com+86 189 7833 1800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026